Trial
NCT03798301
Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
—
Condition
CMV Infection
Intervention
CMV-specific T-cells
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-31